Form D Explorer

Inspect source fieldsReport a record issue

Form D — Belhaven Biopharma Inc.

0001231919-25-000318 · filed Oct 15, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$32,289,627
Reported amount sold
$32,289,627
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Belhaven Biopharma Inc.
CIK
1873965
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2020
Address
84406 Winslow
Chapel Hill, North Carolina 27517
Phone
919-656-8658

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗